Drugnews|藥時事

HEALTHCONN

康聯生醫科技股份有限公司

6665 · Emerging Stock Board

HEALTHCONN focuses on health management, cancer genetic testing, precision diagnostics and cold-chain logistics, as of 2026-11-01.

Pipeline and products

No publicly disclosed new-drug pipeline.

Key events

Related Drugnews articles

No related articles in this language.